Status:
UNKNOWN
Electrical Muscle Stimulation (EMS), a Preventive and Therapeutic Tool for Critical Illness Polyneuromyopathy (CIPNM)
Lead Sponsor:
University of Athens
Conditions:
Critical Illness Polyneuromyopathy (CIPNM)
ICU Acquired Weakness (ICUAW)
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the role of EMS as a preventive and therapeutic tool of CIPNM. The investigators hypothesized that EMS will prevent the development of CIPNM or have a benef...
Detailed Description
CIPNM is one of the most frequent clinical problems encountered in a general ICU. Inflicted patients are characterized by generalized muscle weakness, areflexia, delayed weaning from mechanical ventil...
Eligibility Criteria
Inclusion
- all patients admitted in ICU of Evaggelismos Hospital
Exclusion
- age \< 18 years
- pregnancy
- pre-existing neuromuscular disease (e.g. Gravis)
- connective tissue disease
- fractures or skin lesions that do not allow the implementation of EMS
- BMI \> 35 kg/m2
- brain death
- terminal disease
- length of stay \< 48 hours
- presence of pacemaker
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00882830
Start Date
September 1 2007
End Date
September 1 2015
Last Update
March 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Critical Care Unit, Evaggelismos Hospital, School of Medicine, University of Athens
Athens, Greece, 10676